Selected outcome
before April 2027
84%
before April 2027 · 84%
Stored quote · checking the venue
- Scheduled end
- Nov 1, 2026 ET
- Resolution source
- Food and Drug Administration (opens in a new tab)
Price
Loading price history.
Markets
- before November
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
10%
Open · ~$31 24h · ~$759 vol
Bid 8¢ · Ask 12¢
- before December
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
42%
Open · ~$0 24h · ~$732 vol
Bid 39¢ · Ask 44¢
- before April 2027
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
84%
Open · ~$0 24h · ~$362 vol
Bid 81¢ · Ask 86¢
- before 2027
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
72%
Open · ~$0 24h · ~$194 vol
wide spread 72–96%
Bid 72¢ · Ask 96¢
Event statistics
How this resolves
- Scheduled end
- Nov 1, 2026 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.